Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents May 06, 2024; Volume Issue Supplement 1

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Kang, Fei

    1. Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
      You have access
      Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
      Jingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang and Jing Wang
      Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 38S-45S; DOI: https://doi.org/10.2967/jnumed.123.266314
    2. Landscape of Nuclear Medicine in China and Its Progress on Theranostics
      You have access
      Landscape of Nuclear Medicine in China and Its Progress on Theranostics
      Weidong Yang, Fei Kang, Yue Chen, Zhaohui Zhu, Feng Wang, Chunxia Qin, Jin Du, Xiaoli Lan and Jing Wang
      Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 29S-37S; DOI: https://doi.org/10.2967/jnumed.123.266968
    3. You have access
      Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China
      Liang Zhao, Fei Kang, Yizhen Pang, Jianyang Fang, Long Sun, Hua Wu, XiaoLi Lan, Jing Wang and Haojun Chen
      Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 4S-11S; DOI: https://doi.org/10.2967/jnumed.123.266983
    4. Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
      You have access
      Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
      Xiao Zhang, Zhaoguo Lin, Yuan Feng, Fei Kang, Jing Wang and Xiaoli Lan
      Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 19S-28S; DOI: https://doi.org/10.2967/jnumed.123.266945
  2. Kong, Xiangxing

    1. The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
      You have access
      The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook
      Xiangxi Meng, Xiangxing Kong, Lei Xia, Runze Wu, Hua Zhu and Zhi Yang
      Journal of Nuclear Medicine May 1, 2024, 65 (Supplement 1) 46S-53S; DOI: https://doi.org/10.2967/jnumed.123.266978
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 65 (Supplement 1)
Journal of Nuclear Medicine
Vol. 65, Issue Supplement 1
May 6, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Landscape of Nuclear Medicine in China and Its Progress on Theranostics
  • Clinical Implementation of Total-Body PET in China
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire